Kinetic analysis of IFIT1 and IFIT5 interaction with different native and engineered RNAs and its consequences for designing mRNA-based therapeutics.
In response to foreign RNA cellular antiviral mechanisms stimulate high expression of Interferon-induced proteins with tetratricopeptide repeats (IFITs). Two members of the IFIT protein family: IFIT1 and IFIT5 are capable of binding the very terminal 5' end of mRNA. In eukaryotes these mRNA termini contain a cap structure (m7GpppN, cap 0) that is often subjected to further modifications. Here, we performed a thorough examination of IFIT1 and IFIT5 binding to a wide spectrum of differently capped as well as fully uncapped mRNAs. The kinetic analysis of IFIT1 and IFIT5 interactions with mRNA ligands indicates that the cap structure modifications considerably influence the stability of IFIT1/RNA complexes. The most stable complexes were formed between IFIT1 and GpppG/A- and m7GpppG/A-RNAs. Unexpectedly, we found that NAD+- and NADH-capped RNAs associate with IFIT5 with kinetic parameters comparable to pppG-RNA. Finally, we measured interactions of IFIT1 with mRNAs bearing modified synthetic cap analogs that start to become the important tools in biotechnological and medicinal research. We found that incorporation of modified cap analogs to the RNA protects the latter, to a certain degree, from the translational inhibition caused by IFIT1 protein.